Swiss National Bank’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,580
| Closed | -$704K | – | 2550 |
|
|
2023
Q3 | $704K | Hold |
11,580
| – | – | ﹤0.01% | 2413 |
|
|
2023
Q2 | $762K | Buy |
11,580
+470
| +4% | +$34.4K | ﹤0.01% | 2436 |
|
|
2023
Q1 | $707K | Buy |
11,110
+1,800
| +19% | +$206K | ﹤0.01% | 2423 |
|
|
2022
Q4 | $1.29M | Buy |
+9,310
| New | +$1.31M | ﹤0.01% | 2184 |
|
|
2022
Q2 | – | Sell |
-8,290
| Closed | -$804K | – | 2749 |
|
|
2022
Q1 | $804K | Buy |
8,290
+835
| +11% | +$110K | ﹤0.01% | 2489 |
|
|
2021
Q4 | $1.49M | Sell |
7,455
-4,056
| -35% | -$957K | ﹤0.01% | 2232 |
|
|
2021
Q3 | $2.85M | Buy |
11,511
+85
| +0.7% | +$24.3K | ﹤0.01% | 1820 |
|
|
2021
Q2 | $4.73M | Sell |
11,426
-278
| -2% | -$110K | ﹤0.01% | 1534 |
|
|
2021
Q1 | $4.57M | Buy |
11,704
+147
| +1% | +$72.4K | ﹤0.01% | 1516 |
|
|
2020
Q4 | $6.48M | Buy |
11,557
+231
| +2% | +$146K | ﹤0.01% | 1197 |
|
|
2020
Q3 | $7.92M | Buy |
11,326
+170
| +2% | +$133K | 0.01% | 914 |
|
|
2020
Q2 | $8.82M | Buy |
11,156
+2,872
| +35% | +$2.17M | 0.01% | 825 |
|
|
2020
Q1 | $4.93M | Buy |
8,284
+123
| +2% | +$120K | 0.01% | 945 |
|
|
2019
Q4 | $9.28M | Buy |
8,161
+147
| +2% | +$160K | 0.01% | 809 |
|
|
2019
Q3 | $9.53M | Buy |
8,014
+124
| +2% | +$189K | 0.01% | 771 |
|
|
2019
Q2 | $13M | Buy |
7,890
+200
| +3% | +$346K | 0.01% | 684 |
|
|
2019
Q1 | $15.7M | Buy |
7,690
+294
| +4% | +$518K | 0.02% | 622 |
|
|
2018
Q4 | $9.5M | Buy |
7,396
+208
| +3% | +$319K | 0.01% | 695 |
|
|
2018
Q3 | $13.6M | Buy |
7,188
+463
| +7% | +$957K | 0.02% | 648 |
|
|
2018
Q2 | $13.7M | Buy |
6,725
+101
| +2% | +$230K | 0.02% | 634 |
|
|
2018
Q1 | $14.7M | Buy |
6,624
+247
| +4% | +$628K | 0.02% | 621 |
|
|
2017
Q4 | $14.7M | Buy |
6,377
+586
| +10% | +$1.19M | 0.02% | 626 |
|
|
2017
Q3 | $10.3M | Hold |
5,791
| – | – | 0.01% | 683 |
|
|
2017
Q2 | $7.88M | Buy |
5,791
+633
| +12% | +$764K | 0.01% | 762 |
|
|
2017
Q1 | $6.07M | Hold |
5,158
| – | – | 0.01% | 874 |
|
|
2016
Q4 | $4.12M | Buy |
5,158
+541
| +12% | +$430K | 0.01% | 1079 |
|
|
2016
Q3 | $4.05M | Buy |
4,617
+8
| +0.2% | +$5.79K | 0.01% | 1043 |
|
|
2016
Q2 | $2.58M | Buy |
4,609
+440
| +11% | +$249K | ﹤0.01% | 1328 |
|
|
2016
Q1 | $2.21M | Buy |
4,169
+857
| +26% | +$526K | ﹤0.01% | 1387 |
|
|
2015
Q4 | $2.75M | Buy |
3,312
+38
| +1% | +$38K | 0.01% | 1126 |
|
|
2015
Q3 | $3.63M | Buy |
3,274
+417
| +15% | +$760K | 0.01% | 943 |
|
|
2015
Q2 | $6.23M | Buy |
2,857
+487
| +21% | +$992K | 0.02% | 689 |
|
|
2015
Q1 | $3.71M | Hold |
2,370
| – | – | 0.01% | 932 |
|
|
2014
Q4 | $2.82M | Buy |
2,370
+749
| +46% | +$500K | 0.01% | 1052 |
|
|
2014
Q3 | $753K | Buy |
1,621
+347
| +27% | +$160K | ﹤0.01% | 1828 |
|
|
2014
Q2 | $636K | Buy |
1,274
+340
| +36% | +$109K | ﹤0.01% | 2018 |
|
|
2014
Q1 | $275K | Buy |
934
+602
| +181% | +$182K | ﹤0.01% | 2348 |
|
|
2013
Q4 | $90K | Buy |
+332
| New | +$92.8K | ﹤0.01% | 2485 |
|
Other funds holding BLUE
GIM
PAI
GCM
Swiss National Bank's BLUE Position: Q4 2023 in Review
Swiss National Bank sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 11,580 shares — an estimated $704K sold.
Swiss National Bank first reported a position in BLUE in Q4 2013 and held it in 38 quarters. The position peaked at $15.7M in Q1 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.
- Swiss National Bank reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
- Swiss National Bank sold 11,580 bluebird bio shares in Q4 2023, an estimated $704K.
- Swiss National Bank first reported a position in bluebird bio in Q4 2013 and held it in 38 quarters.
- Swiss National Bank's bluebird bio position peaked at $15.7M in Q1 2019.
- 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.